✦ LIBER ✦

Lithium treatment in adults with acute myeloid leukemia receiving chemotherapy

✍ Scribed by Horns, Richard C. ;Schrier, Stanley L. ;Greenberg, Peter L.

Publisher: John Wiley and Sons
Year: 1984
Tongue: English
Weight: 292 KB
Volume: 12
Category: Article
ISSN: 0098-1532
DOI: 10.1002/mpo.2950120305

No coin nor oath required. For personal study only.

✦ Synopsis

To determine whether lithium can shorten chemotherapy-induced neutropenia, 35 adult patients with newly diagnosed acute myeloid leukemia undergoing initial chemotherapy were randomized either to receive oral lithium started at the time of biopsy-proven hypoplasia or to receive no lithium. This study failed to show statistically significant shortening of the duration of chemotherapy-induced neutropenia in the lithium treatment group.

📜 SIMILAR VOLUMES

Telomerase activity is prognostic in ped

Telomerase activity is prognostic in pediatric patients with acute myeloid leukemia : Comparison with adult acute myeloid leukemia

✍ Srdan Verstovsek; Taghi Manshouri; Franklin O. Smith; Francis J. Giles; Jorge Co 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 2 views

## Abstract ## BACKGROUND Significantly elevated telomerase activity (TA) has been found in samples from patients with almost all malignant hematologic diseases. The impact of elevated TA on the course of pediatric patients with acute myeloid leukemia (P‐AML) is unknown. ## METHODS Using a modif

Impact of remission induction chemothera

Impact of remission induction chemotherapy on survival in older adults with acute myeloid leukemia

✍ Rachid Baz; Cristina Rodriguez; Alex Z. Fu; Rony Abou Jawde; Matt Kalaycio; Anja 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

## Abstract ## BACKGROUND. Significant controversy surrounds the use of remission induction chemotherapy (IC) in older adults with acute myeloid leukemia (AML). Earlier clinical trials have yielded conflicting results and possibly a minor survival benefit, often offset by a longer hospitalization

Acute pulmonary failure during remission

Acute pulmonary failure during remission induction chemotherapy in adults with acute myeloid leukemia or high-risk myelodysplastic syndrome

✍ Ali Al Ameri; Charles Koller; Hagop Kantarjian; Farhad Ravandi; Srdan Verstovsek 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB 👁 2 views

Unexpected hepatotoxicity after priming

Unexpected hepatotoxicity after priming and treatment with molgramostim (rhGM-CSF) in acute myeloid leukemia during induction chemotherapy

✍ Dr. Per Boye Hansen; Hans E. Johnsen; Jens Otto Lund; Mogens Sandbjerg Hansen; N 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 302 KB

Infections and association with differen

Infections and association with different intensity of chemotherapy in children with acute myeloid leukemia

✍ Lillian Sung; Alan Gamis; Todd A. Alonzo; Allen Buxton; Kristen Britton; Joetta 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB

Prospective cytomegalovirus monitoring d

Prospective cytomegalovirus monitoring during first-line chemotherapy in patients with acute myeloid leukemia

✍ Saveria Capria; Giuseppe Gentile; Angela Capobianchi; Luisa Cardarelli; Valentin 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

## Abstract Little is known about the incidence and clinical impact of cytomegalovirus (CMV) infection in patients with acute myeloid leukemia at the time of diagnosis and during chemotherapy. The aims of the present study were to assess prospectively the incidence of active CMV infection in 69 con